ClosedPublished 20 Oct 2023

Ayala Pharmaceuticals, Inc. /
Biosight, Ltd.

Ayala Pharmaceuticals completes merger with Biosight

Buy side: Ayala Pharmaceuticals, Inc.
Buy sideAyala Pharmaceuticals, Inc.
Target: Biosight, Ltd.
TargetBiosight, Ltd.
Source · 20 Oct 2023
Buy side: Ayala Pharmaceuticals, Inc.
Buy sideAyala Pharmaceuticals, Inc.
Target: Biosight, Ltd.
TargetBiosight, Ltd.
01 / BuyerAyala Pharmaceuticals, Inc.
02 / TargetBiosight, Ltd.
01

What happened

Ayala Pharmaceuticals, Inc. completed its merger with Biosight, Ltd., which will continue as a wholly owned subsidiary of Ayala.

The combined company will operate under the name Ayala Pharmaceuticals, Inc. Terms weren't disclosed.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Ayala Pharmaceuticals completes merger with Biosight

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.